Evaluation of Masood's and Modified Masood's Scoring Systems in the Cytological Diagnosis of Palpable Breast Lump Aspirates

对 Masood 评分系统和改良 Masood 评分系统在触诊可及乳腺肿块穿刺液细胞学诊断中的应用进行评价

阅读:1

Abstract

INTRODUCTION: Fine Needle Aspiration Cytology (FNAC) has a leading role in the assessment of breast lesions. Masood's Scoring Index (MSI) and its modification (Modified Masood's scoring index; MMSI) has been proposed to aid in sub-grouping breast lesions and to help in subsequent management. AIM: To assess and compare the diagnostic accuracy of MSI and MMSI by subsequent correlation with histopathology. MATERIALS AND METHODS: The study was cross-sectional in nature and was conducted in a tertiary care setting. The study included 207 cases presenting as palpable breast lump, which had undergone FNAC and subsequent excision biopsy for histopathology. STATISTICAL ANALYSIS: The cases were grouped into four categories as suggested by Masood et al., (MSI) and Nandini et al., (MMSI) and concordance analysis with reference to histopathological diagnosis was done. RESULTS: In comparison to MSI, MMSI showed better concordance with histopathological diagnosis and superior diagnostic accuracy in non-proliferative breast disease category (p-value = 0.046) as well as in proliferative breast disease without atypia category. The overall diagnostic accuracy of the cytological scoring was 97.5%, with 94.5% sensitivity and 100% specificity. CONCLUSION: Though both MSI and MMSI were found effective in subcategorizing breast lesions, MMSI was found to have better concordance with histopathology. Inclusion of cellular pattern and background material may further help in increasing the accuracy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。